| Abstract: |
Magnetic resonance imaging (MRI) is an integral part of breast imaging due to its high sensitivity in identifying malignancy and high-risk lesions (0.88–0.92, 95% confidence interval) (Mcgrath et al., J Magn Reson Imaging 46(3):631–645, https://doi.org/10.1002/jmri.25738, 2017) and its comparability in positive predictive value to that of conventional imaging (15–30%). However, its specificity is lower (0.67–0.77, 95% confidence interval) (Mcgrath et al., J Magn Reson Imaging 46(3):631–645, https://doi.org/10.1002/jmri.25738, 2017; Myers et al., Clin Breast Cancer 15(2):143–152, https://doi.org/10.1016/j.clbc.2014.11.003, 2015) due to an overlap in imaging characteristics between benign and malignant lesions. Histologic sampling is therefore sometimes needed. © 2022, Springer Nature Switzerland AG. |
